#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Brian Lichty Email
Founder, CEO . Esphera SynBio
How to contact Brian Lichty
Join and see Brian's contact info for free!Current Roles
Employees:
12Revenue:
$1.9MAbout
Esphera SynBio is developing next-generation cancer and immunoregulatory treatments through its innovative synthetic biology platform. The company develops advanced nanomedicines in the form of functionalized vesicles, which can be produced either in vitro or in vivo through their proprietary transgene technology. Esphera’s lead clinical candidate represents a novel approach in cancer immunotherapy - an off-the-shelf treatment that triggers tumor cells to generate a bespoke personalized cancer vaccine in vivo. Beyond oncology, Esphera's versatile platform shows promise in broader immunomodulation applications.Esphera SynBio Address
Ottawa, ON
ca